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INTRODUCTION
Liquid-liquid phase separation (LLPS) mediates the assembly of many non-membrane-bound compartments in cells such as nucleoli, stress granules, and signaling clusters (Aguzzi and Altmeyer, 2016; Banani et al., 2017; Shin and Brangwynne, 2017) . These membrane-less structures have defined boundaries, allowing molecules to be concentrated within compartments while maintaining continuous exchange with the surrounding solutions (Aguzzi and Altmeyer, 2016; Banani et al., 2017; Shin and Brangwynne, 2017) . By creating distinct physical and biochemical compartments, phase separation facilitates temporal and spatial control of signaling and biochemical reactions (Bergeron-Sandoval et al., 2016; Banani et al., 2017) . LLPS is triggered by multivalent interactions mediated by intrinsically disordered regions (IDRs) in proteins or by protein-interacting domains (Bergeron-Sandoval et al., 2016; Banani et al., 2017; Shin and Brangwynne, 2017) . Protein-RNA interactions also contribute to LLPS-mediated formation of RNP granules such as stress granules and P bodies (Molliex et al., 2015; Lin et al., 2015) . Phase-separated liquid-like structures can transition into less dynamic gel-like structures and/or inert protein aggregates (Lin et al., 2015; Patel et al., 2015) . Phase separation and transition are modulated by the composition and concentration of key molecules and by post-translational modification (PTM) (Molliex et al., 2015; Banani et al., 2016) . PTMs, including phosphorylation, methylation, ubiquitination, and sumoylation, regulate protein-protein or protein-RNA interaction strengths to modulate LLPS ( Shin and Brangwynne, 2017) . Very little is known about how formation and transition of phase-separated structures are correlated with their physiological function.
The germline P granule in one-cell-stage C. elegans embryos is one of best-characterized structures assembled via LLPS (Brangwynne et al., 2009 ). Upon fertilization, P granules derived from the oocyte dissolve in the anterior region, which is destined to give rise to the somatic blastomere, while they enlarge in the posterior region, which generates the germline blastomere (Brangwynne et al., 2009; Gallo et al., 2010) . The differential condensation boundary of P granules spanning the anteriorposterior axis is specified by gradients of granule scaffold MEG proteins (Wang et al., 2014; Smith et al., 2016) . MEG proteins also undergo LLPS, which is regulated by RNA-binding and spatially controlled phosphorylation (Wang et al., 2014; Smith et al., 2016) . During subsequent development, P granules are specifically localized in germline blastomeres P2, P3, and P4 and eventually partitioned into the germline precursor cells Z2 and Z3 derived from P4 (Strome, 2005) .
During asymmetric cell divisions that generate germline blastomeres, components of P granules partitioned into the sister somatic blastomeres are removed (Yang and Zhang, 2014) . Among the P granule components, PGL-1 and PGL-3 are selectively degraded by autophagy (Zhang et al., 2009), a process involving (A-E) DIC images of droplets formed by purified PGL-3 (A), PGL-1 (B) , a mixture of PGL-1/PGL-3 proteins (C) , SEPA-1 (D) , and a mixture of SEPA-1/PGL-1/PGL-3 proteins (E) at 3 mM of each. His-tagged PGL-1 and PGL-3 and MBP-tagged SEPA-1 were used for LLPS unless otherwise noted. MBP alone does not affect LLPS of PGL-1/-3. MBP-tagged SEPA-1 promotes LLPS of PGL-1/-3 as effectively as non-tagged SEPA-1 but is more soluble and stable. the sequestration of substrates in the double-membrane autophagosome and its subsequent delivery to lysosomes for degradation (Feng et al., 2014) . PGL-1 and PGL-3 accumulate into numerous granules, named PGL granules, in somatic cells of autophagy mutant embryos (Zhang et al., 2009) . In autophagic degradation of selective cargoes, selectivity is conferred by a receptor protein that simultaneously binds to the cargo and the autophagy protein Atg8 (Stolz et al., 2014) . The self-oligomerizing protein SEPA-1 acts as the receptor for degradation and formation of PGL granules (Zhang et al., 2009 ). In sepa-1 mutants, PGL-1/-3 proteins diffusely localize in somatic cells and fail to be removed (Zhang et al., 2009) . PGL-1 degradation and accumulation of PGL-1 into granules also require PGL-3 (Zhang et al., 2009) . SEPA-1 directly interacts with LGG-1 (the C. elegans Atg8 homolog) and PGL-3, and PGL-3 in turn interacts with PGL-1 (Zhang et al., 2009) . The scaffold protein EPG-2, which directly interacts with SEPA-1 and LGG-1, is also essential for degradation of PGL granules (Tian et al., 2010) . Both SEPA-1 and EPG-2 are zygotically synthesized and removed by autophagy (Zhang et al., 2009; Tian et al., 2010) . Degradation of PGL-1 and PGL-3 is modulated by post-translational arginine methylation in the (Arg-Gly-Gly) RGG domains, which is mediated by the PRMT1 homolog EPG-11 (Li et al., 2013) . How these multi-layered regulatory mechanisms act concertedly to mediate efficient removal of PGL-1 and PGL-3 in somatic cells is poorly understood.
Here, we demonstrated that autophagic degradation of PGL granules is specified by phase separation and transition that are controlled by SEPA-1, EPG-2, and PTMs. SEPA-1 promotes LLPS of PGL-1 and PGL-3. EPG-2 determines the size of droplets and also converts them into gel-like structures. Under heat-stress conditions, mTORC1-mediated phosphorylation of PGL-1/-3 is elevated and PGL-1/-3 undergo accelerated phase separation, forming PGL granules that are resistant to autophagic degradation. Accumulation of PGL granules maintains embryonic viability during heat stress. Our study reveals that mTORC1 signaling modulates LLPS of PGL granules to coordinate autophagic degradation and heat-stress adaptation during development.
RESULTS
The Receptor Protein SEPA-1 Promotes LLPS of PGL-1/-3 In PGL-3-depleted embryos, PGL-1 fails to be removed and is diffusely localized (Zhang et al., 2009 ). PGL-3 undergoes LLPS (Saha et al., 2016) , so we determined whether PGL-3 facilitates LLPS of PGL-1. Differential interference contrast (DIC) microscopy revealed that purified PGL-3 protein formed spherical droplets at a concentration of 3 mM in low-salt buffer (LS, 150 mM NaCl) (Figure 1A) . PGL-1 also formed droplets at 3 mM, but they were smaller and less abundant than PGL-3 droplets (Figure 1B) . When PGL-3 and PGL-1 were mixed, larger droplets formed compared with PGL-3 or PGL-1 alone (Figures 1C and 1F) . Mixing PGL-1 and PGL-3 also lowered the concentration of each protein required for LLPS (Figures S1A-S1G). Neither PGL-1 nor PGL-3 formed droplets at 0.2 mM, but they formed a few droplets in reactions containing 0.5 mM of the other protein (Figures S1E-S1G). We separated droplets from the solution phase by sedimentation and determined the levels of PGL-1 and PGL-3 in each fraction by immunoblotting ( Figures  1I and S1H) . Co-addition of 3 mM PGL-1 and PGL-3 resulted in more proteins partitioned into droplets than the reaction containing either protein alone ( Figure S1H ), Thus, PGL-3 and PGL-1 (F) Column scatter charts show the droplet size in reactions containing PGL-1 (n = 195), PGL-3 (n = 391), PGL-1/-3 (n = 465), and SEPA-1/PGL-1/-3 (n = 218). Data are shown as mean ± SEM of droplets combined from three fields (220 3 166 mm) for each reaction. (G) At 0.5 mM, PGL-1:: :mCherry form a few droplets, and this is enhanced by co-addition of SEPA-1. Confocal images are shown. (H) The number of PGL-1/-3 droplets per field (105 3 105 mm) in reactions containing different SEPA-1 concentrations shown in (G) . Three fields were quantified for each. Data are shown as mean ± SEM. (I) Diagram of the sedimentation assay to separate the condensed liquid phase and the aqueous phase for immunoblotting assays. (J) PGL-1, PGL-3, and SEPA-1 levels in the solution (supernatant, S) and separated droplets (pellet, P). Protein levels in the pellet are normalized by the levels of the corresponding proteins in the supernatant in the corresponding reaction, which is set to 1.00. (O) , which is suppressed in embryos grown in medium containing 200 mM NaCl (P) . PGL-3::GFP expression is driven by the sepa-1 promoter and thus is absent in germline cells. Bars for embryos, which remain the same size during embryogenesis, are only shown once in each figure. (Q and R) Spinning disk microscopy images showing fusion (Q) and fission (R) behaviors (red arrows) of PGL-3::GFP granules in pgl-3::gfp(oe) embryos grown at 20 C.
( S and T) Arginine methylation of PGL-1 and PGL-3 by EPG-11 attenuates LLPS of PGL-1/PGL-3. Purified PGL-1 and PGL-3 (1 mM each) were incubated with EPG-11 in the presence or absence of the arginine methylation donor SAM (S) . Addition of SAM alone in the reaction has no effect on LLPS of PGL-1/-3. Column scatter charts show the droplet size in the absence (n = 158) or presence (n = 463) of SAM (T) . Data are shown as mean ± SEM of droplets combined from three fields (220 3 166 mm) for each reaction. (U) Unmethylated PGL-1 and PGL-3 form a few droplets, while methylated PGL-1 and PGL-3 fail to form droplets (0.5 mM for each protein).
(V) The number of droplets per field (220 3 166 mm) in reactions containing modified or non-modified PGL-1/-3. Three fields were quantified for each reaction. Data are shown as mean ± SEM. (W) Sedimentation/immunoblotting assays show that arginine methylation of PGL-1 and PGL-3 inhibits partition of PGL-1 and PGL-3 into droplets. Quantification of PGL-1 and PGL-3 levels (normalized by the levels of the corresponding protein in the supernatant) is also shown. Scale bars: 10 mm for (A)-(E), (G) , (L)-(S), and (U), insets in (A)-(E), (G) , (S) , (U) , and the left image in (M) ; 100 mm in inset in the right image in (M); and 5 mm in enlarged images in (Q) and (R) . See also Figures S1 and S2.
promote LLPS of each other. Formation of PGL-1/-3 droplets was sensitive to salt concentration ( Figure S1I ). When PGL-1/-3 droplets met, they fused and coalesced into a larger droplet (Figure S1J) . PGL-1/-3 droplets grew in size over time and became irregularly shaped ( Figure S1K ). PGL-1/-3 droplets exhibited a wetting phenotype when touching the surface of a coverslip (Figure S1L) . Thus, PGL-1/-3 droplets possess properties of liquid droplets.
We next examined whether SEPA-1 modulates LLPS of PGL-1/-3. Purified SEPA-1 failed to phase separate ( Figure 1D ). Co-addition of SEPA-1 promoted LLPS of PGL-3 and PGL-1/-3, but not PGL-1 alone ( Figures 1E-1H and S1E-S1G). In the presence of SEPA-1, larger droplets formed and more PGL-1/-3 proteins partitioned into droplets ( Figures 1E, 1F , and S1M). SEPA-1 also lowered the threshold for LLPS of PGL-1 and PGL-3. Phase separation was not observed in a mixture of PGL-1:: ::mCherry at 0.2 mM but was promoted by SEPA-1 in a concentration-dependent manner ( Figures S1N and S1O ). PGL-1, PGL-3, and SEPA-1 proteins were all present in the droplets, and they were colocalized in the same liquid phase ( Figures  1I, 1J , S1P, and S1Q). Formation of SEPA-1/PGL-1/-3 droplets was also sensitive to salt concentration ( Figure 1K ). The SEPA-1/PGL-1/-3 droplets exhibited fusion, wetting, and growth phenotypes ( Figures 1L-1N ). These results indicate that SEPA-1 lowers the LLPS boundary of PGL-1/-3 and promotes LLPS of PGL-1/-3.
The regions in PGL-1, PGL-3, and SEPA-1 that are involved in LLPS were mapped using truncated proteins. Both PGL-1 and PGL-3 contain RGG domains at their C termini (Figures S1R and S1S) . No LLPS was observed with mutant PGL-1 and PGL-3 lacking the RGG domain, or with the RGG domain alone (Figures S1R-S1T). Deleting the N terminus of PGL-1 or PGL-3 also greatly impaired their separation into droplets (Figures S1R-S1U). Interestingly, co-addition of various PGL-1 fragments reduced the size of droplets formed by PGL-3 or SEPA-1/PGL-3 (Figures S1R, S1V, and S1W). PGL-3 fragments also inhibited LLPS of PGL-1 ( Figure S1S ). PGL-1 and PGL-3 self-interacted and also interacted with each other. The interactions were mediated by the RGG domain and several other regions (Figures S1R and S1S) . The region in SEPA-1 that promotes LLPS of PGL-1/-3 was delineated to the N-terminal region, which contains the PGL-3-binding domain ( Figures S2A and S2B) . Thus, LLPS of SEPA-1/PGL-1/-3 is mediated by multivalent interactions that depend on the RGG domain and multiple other regions. Pre-treatment of PGL-1, PGL-3, and SEPA-1 proteins with RNase A or addition of purified MBP, BSA, and GFP proteins in the reactions had no effect on LLPS of PGL-1/-3, or on the LLPS-promoting function of SEPA-1 (Figures S2C-S2H) .
During the early stages of embryogenesis at 20 C, only few, very faint PGL granules are detected in somatic cells (Li et al., 2013) . In embryos overexpressing , a large number of spherical granules containing SEPA-1/PGL-1/-3 accumulated ( Figures 1O and S2I-S2K ), which was suppressed by increasing the salt concentration from 35 mM NaCl in normal growth medium to 200 mM ( Figure 1P ). These PGL granules underwent fusion and fission processes ( Figures 1Q and 1R ). Thus, PGL granules formed by increased levels of PGL-3 in embryos exhibit liquid properties.
Arginine Methylation of PGL-1 and PGL-3 Inhibits LLPS PGL-1/-3 proteins are diffusely localized in somatic cells in sepa-1 mutants and form numerous granules in sepa-1; epg-11 mutants (Li et al., 2013) . PGL-1 and PGL-3 are modified at multiple sites in the RGG domains by EPG-11 (Li et al., 2013) . To examine whether methylation of PGL-1/-3 modulates LLPS, purified proteins were methylated by EPG-11 and used for LLPS assays. The droplets formed by methylated PGL-1/-3 (1 mM for each protein) were much smaller than non-modified ones ( Figures 1S and 1T ). At the concentration of 0.5 mM, PGL-1/-3 formed droplets, while methylated PGL-1/-3 did not (Figures 1U and 1V) . Immunoblotting with an antibody against methylated arginine showed that methylated PGL-1 and PGL-3 were present in the droplets ( Figure 1W ). Compared to droplets formed by non-modified PGL-1/-3, fewer PGL-1 and PGL-3 proteins were separated into the droplets formed by methylated PGL-1/-3 ( Figure 1W ). Arginine methylation also reduced the LLPS of SEPA-1/PGL-1/-3 ( Figures S2L and  S2M ). In summary, LLPS of PGL granules is inhibited by arginine methylation of PGL-1 and PGL-3. A) DIC images of EPG-2/SEPA-1/PGL-1/-3 droplets formed for the indicated time. His-tagged EPG-2 was used for LLPS. RNase A treatment and addition of BSA, MBP, and GFP proteins have no effect on the role of EPG-2 in modulating LLPS of SEPA-1/PGL-1/-3. (B) Column scatter charts show the size of EPG-2/SEPA-1/PGL-1/-3 droplets (3 mM for each protein) formed for 1 min (n = 360), 1 hr (n = 260), 4 hr (n = 229), and 12 hr (n = 187). Data are shown as mean ± SEM of droplets combined from three fields (220 3 166 mm) for each reaction. (C) Confocal fluorescence images showing that EPG-2::GFP (3 mM) coats the SEPA-1/PGL-1/-3 droplets. (D) EPG-2::GFP (0.6 mM) forms small dots that decorate the surface of SEPA-1/PGL-1/-3 droplets. Upper panels in (C) and (D) are maximum projections of confocal z stacks. Bottom panels show single-plane confocal images. (E) In lgg-1 mutant embryos, EPG-2 forms ring-like structures, encircling the GFP::PGL-3 dots. The germline-expressed PGL-3 reporter, , was used to label PGL granules. gfp::pgl-3 does not cause accumulation of PGL granules in somatic cells. (F) In pgl-3::gfp(oe) embryos, EPG-2 forms a few small aggregates that associate with, but do not overlap with, PGL granules. DAPI images of the embryos are shown in the left panels. (E) and (F) are 3D deconvolution images. (G-I) EPG-2 aggregates accumulate in pgl-3::gfp(oe) embryos grown at 20 C at the $100 cell stage (G) , but they are smaller than those in lgg-1 mutants (H) .
Quantitative fluorescence intensity data are shown as mean ± SD (n = 3 focal planes from 3 embryos) (I) . The intensity in pgl-3::gfp(oe) embryos is set to 1.0. *p < 0.05. (G) and ( EPG-2 Controls the SEPA-1/PGL-1/-3 Droplet Size and Coats the Droplet Surface Purified EPG-2 failed to undergo LLPS alone, or with SEPA-1 ( Figures S2N and S2O ). Co-addition of EPG-2 reduced the size of droplets formed by PGL-1/-3 and SEPA-1 (Figures 2A and  2B ). The EPG-2-containing droplets remained small even 12 hr after formation (Figures 2A and 2B ), and their fusion was greatly inhibited ( Figure S2P ). Addition of EPG-2 into pre-formed SEPA-1/PGL-1/-3 droplets also inhibited their further growth in size ( Figure S2Q ). EPG-2 protein was detected in the SEPA-1/PGL-1/-3 droplets by immunoblotting ( Figure S2R ). Using EPG-2::GFP, we found that EPG-2 (3 mM) did not mix into the SEPA-1/PGL-1/-3 (3 mM for each protein) droplets, but non-homogeneously coated the surface of the droplets ( Figure 2C ). EPG-2::GFP also enveloped pre-formed SEPA-1/PGL-1/-3 droplets ( Figure S2S ). At a low concentration (0.6 mM), EPG-2 formed small dots that decorated the SEPA-1/PGL-1/-3 droplets in a scattered pattern ( Figure 2D ).
We acquired 3D deconvolution images to examine the structures of PGL granules and EPG-2 during embryogenesis. EPG-2 aggregates are detected in early-stage embryos but are absent from the $200 cell stage onward (Li et al., 2013) . In autophagy mutant embryos, PGL-1, PGL-3, SEPA-1, and EPG-2 accumulate into numerous punctate structures (Zhang et al., 2009; Tian et al., 2010) . PGL-1 and PGL-3 dots, and SEPA-1 and PGL-3 dots, were almost completely colocalized ( Figures S3A and S3B ). However, EPG-2 formed ring-like structures, encircling the GFP::PGL-3 dots, and also formed punctate structures that associated with PGL granules (Figure 2E ). In pgl-3(oe) embryos, autophagic degradation of EPG-2 still occurred ( Figures 2F-2I and S3C) , and the small EPG-2 dots associated with, but did not overlap with, PGL granules ( Figure 2F ). Therefore, EPG-2 also exhibits immiscibility with PGL granules in embryos.
EPG-2 Promotes the Liquid-to-Gel-like Transition of PGL Droplets Liquid droplets dissolve in high-salt solutions and the molecules in the droplet exhibit high mobility. When the droplets transition into gel-like or solid structures, they become resistant to high salt and the molecules are less dynamic. After formation for 1 min in LS buffer (150 mM NaCl), PGL-1/-3 droplets and SEPA-1/PGL-1/-3 droplets dissolved when the salt concentration was increased to 500 mM (high-salt buffer, HS) (Figures S3D and S3E) . When droplets were allowed to form for a longer time, a proportion of them persisted in HS buffer, and the PGL-1::GFP fluorescence intensity was not homogeneous throughout the droplets (Figures S3G-S3J ). The SEPA-1/PGL-1/-3 droplets that persisted in high salt were larger than the persistent PGL-1/-3 droplets ( Figures S3H and S3J ). EPG-2/SEPA-1/PGL-1/-3 droplets that formed in LS buffer in the first few minutes dissolved in HS buffer but gradually became resistant to high salt (Figure S3F) . They largely persisted when the formation time in LS buffer was extended to 2 hr ( Figures S3K and S3L) . Therefore, EPG-2 increases the salt resistance of SEPA-1/PGL-1/-3 droplets.
To examine the mobility of PGL-1::GFP molecules in droplets after different formation times, we performed fluorescence recovery after photobleaching (FRAP) analysis. In PGL-1/-3 droplets formed for 1 hr, the PGL-1::GFP fluorescence signal completely recovered 24 s after bleaching ( Figure 2J ). When the droplets were allowed to form for a longer time, the fluorescence recovery time was decreased ( Figure 2J ). In SEPA-1/PGL-1/-3 droplets, recovery of PGL-1 fluorescence after bleaching was slower than in PGL-1/-3 droplets formed for the same time ( Figure 2K ). The recovery of PGL-1 was even slower in EPG-2/SEPA-1/PGL-1/-3 droplets ( Figure 2L ). Only 60% of the fluorescence recovered in droplets formed for 1 hr and hardly any fluorescence recovered in droplets formed for 4 hr or more ( Figure 2L ). Thus, the EPG-2-containing droplets were much less mobile. Addition of a low concentration of EPG-2 (0.6 mM) also reduced the growth and mobility of SEPA-1/PGL-1/-3 droplets, but the reduction was less severe than with co-addition of 3 mM EPG-2 ( Figures S3M and S3N ), indicating that EPG-2 regulates the biophysical properties of SEPA-1/PGL-1/-3 droplets in a concentration-dependent manner. The region in EPG-2 that reduces the size and mobility of SEPA-1/PGL-1/-3 droplets was mapped to a fragment containing amino acids 352-690, which binds to SEPA-1 ( Figures S3O-S3Q ). These results indicate that EPG-2/SEPA-1/PGL-1/-3 liquid-like droplets develop gel-like characteristics over time, including impaired fusion (E) After formation for 1 and 12 hr, SEPA-1/PGL-1(P55S, L82P, and E360K)/PGL-3 droplets are smaller than SEPA-1/PGL-1/-3 droplets. SEPA-1/PGL-1(L82P)/ PGL-3 droplets form clusters and have a spiky appearance instead of being smooth in shape. (F) Column scatter charts show the size of droplets formed for 1 hr in reactions containing wild-type PGL-1 (n = 104), PGL-1(E360K) (n = 193), PGL-1(P55S) (n = 184), and PGL-1(L82P) (n = 395). Data are shown as mean ± SEM of droplets combined from three fields (220 3 166 mm) for each reaction. (G and H) Wild-type PGL-1::GFP is distributed homogeneously in SEPA-1/PGL-1/-3 droplets (G) . PGL-1(E360K)::GFP also forms bright dots that decorate the droplet (H) . Images are maximum projections of confocal z stacks. (I and J) FRAP analysis of SEPA-1/PGL-1/-3 droplets containing wild-type or mutant PGL-1 after 1 hr of formation (I) . PGL-1(E360K)::GFP forms some dots on the surface and inside the droplets. Quantitative FRAP data are shown as mean ± SD (n = 5) in (J).
capability, increased resistance to high salt, and reduced dynamics.
We also performed FRAP analysis to compare the mobility of PGL-3::GFP in PGL granules in lgg-1 mutants, in which PGL granules are encircled by EPG-2, and in epg-2; lgg-1 mutants, in which EPG-2 is depleted. About 10% of PGL-3::GFP fluorescence recovered in 1 min after bleaching in lgg-1; pgl-3(oe) embryos, while $35% recovered in epg-2; lgg-1; pgl-3(oe) embryos ( Figures 2M-2O ). Therefore, EPG-2 reduces the mobility of PGL granules during embryogenesis.
PGL Granules Accumulate in Somatic Cells under HeatStress Conditions
In wild-type embryos, almost no PGL granules are detected, suggesting that their degradation is fast or the size of granules degraded by autophagy is small. However, in embryos laid under heat-stress conditions (by animals that were shifted from 20 C to 26 C at the L4 stage), a large number of PGL granules accumulated and persisted in somatic cells . The same phenotype was observed when the animals were shifted to a temperature higher than 26 C. Embryos grown at 26 C were characterized in this study. PGL granules were detected in embryos generated from the cross of pgl-3(+) hermaphrodites with pgl-3(-) males, but were absent in embryos born from pgl-3(-) hermaphrodites mated with pgl-3(+) males (Figures 3F and 3G) , indicating that the accumulated PGL-3 proteins in somatic cells at 26 C are derived from the oocyte. In embryos grown at 20 C, SEPA-1 aggregates are detected in early-stage embryos but are absent at the comma stage onward due to autophagic degradation (Zhang et al., 2009) . SEPA-1 aggregates persisted throughout embryogenesis and colocalized with PGL granules at 26 C ( Figures 3D, 3E , and S4A-S4F). PGL granules became evident at the $20 cell stage and then gradually increased and persisted throughout embryogenesis at 26 C ( Figures S4A-S4F ), indicating that diffuse PGL-1/-3 proteins gradually separate into granules with SEPA-1. PGL granules in embryos at 26 C were spherical, underwent fusion and fission processes, and disappeared in growth medium containing 200 mM NaCl ( Figures 3I-3K ). Thus, PGL granules exhibit liquid phase properties in embryos under heat stress.
Levels of PGL-1, PGL-3, and SEPA-1 proteins were higher in embryos grown at 26 C than at 20 C and were comparable to the levels in autophagy mutants ( Figure 3H ). Their mRNA levels were not increased ( Figure S4G ). Degradation of other autophagy substrates, including SQST-1 and EPG-7 (Yang and Zhang, 2014), was not affected (Figures S4H-S4K ), indicating that basal autophagy activity is not generally impaired in embryos at 26 C. Autophagic degradation of EPG-2 is independent of PGL-1, PGL-3, and SEPA-1 (Tian et al., 2010) . Levels of EPG-2 protein were higher in embryos at 26 C than at 20 C, but the increase was much smaller than that in autophagy mutants . Small EPG-2 dots closely associated with, but did not overlap with, PGL granules in embryos at 26 C (Figure 3N) . Therefore, autophagic degradation of EPG-2 still occurs in embryos at 26 C. In animals overexpressing epg-2, the number of PGL granules and the levels of PGL-1 and PGL-3 were dramatically decreased at 26 C ( Figures 3L, 3M , S4P, and S4Q). These results suggest that, under heat-stress conditions, EPG-2 levels are insufficient to specify the properties of PGL granules that make them amenable to autophagic degradation.
Mutations in PGL-1 that Promote Transition of PGL Droplets into Gel-like Structures Suppress PGL Granule Accumulation during Heat Stress To investigate the mechanism underlying the accumulation of PGL granules during heat stress, we performed genetic screens to identify mutations that suppress the accumulation of GFP::PGL-1 granules in embryos at 26 C. As expected, mutant alleles of pgl-3 and sepa-1 were isolated, and they resulted in diffuse localization of GFP::PGL-1 in somatic cells ( Figures  S5A-S5C ). Accumulation of SEPA-1 aggregates in embryos at 26 C was suppressed by depletion of PGL-1 or PGL-3 ( Figures  S5D-S5F ). In PGL-1-depleted embryos, GFP::PGL-3 was also absent in somatic cells (Figure S5G ). We also isolated three alleles of pgl-1, bp924, bp926, and bp927 that suppressed the accumulation of PGL-1 granules at 26 C ( Figures 4A-4D and S5H-S5J). bp924, bp926, and bp927 introduced the P55S, L82P, and E360K mutations, respectively, into PGL-1 (Figure S5K) . Formation of germline P granules was not affected in these pgl-1 mutants ( Figures S5L-S5O) .
We next determined whether these PGL-1 mutations affect the biophysical properties of PGL-1/-3, which are essential for autophagic degradation. When mixed with SEPA-1 and PGL-3, PGL-1(E360K), PGL-1(P55S), or PGL-1(L82P) mutant protein (3 mM) resulted in formation of smaller droplets than wild-type PGL-1 ( Figures 4E and 4F ). The PGL-1(P55S) and PGL-1(L82P)-containing droplets remained small over time (Figure 4E ). The PGL-1(E360K)-containing droplets grew after 12-hr formation but were much smaller than droplets containing wild-type PGL-1 ( Figure 4E ). Mutant PGL-1 acted dominantly in the presence of wild-type PGL-1 to induce the formation of small SEPA-1/PGL-1/PGL-3 droplets ( Figure S5P ). PGL-1(P55S):: GFP and PGL-1(L82P)::GFP were incorporated into the droplets ( Figures S5Q-S5S ). In addition to mixing into the droplets, PGL-1(E360K)::GFP formed some bright dots located on the surface and also inside the droplets ( Figures 4G and 4H ). Mutant PGL-1 proteins increased the resistance of SEPA-1/PGl-1/-3 to high salt ( Figure S5T ). The fluorescence recovery of SEPA-1/ PGL-1(P55S, L82P, and E360K)/-3 droplets after 1-hr formation was greatly impaired with only 20%$30% recovery compared to $100% recovery in SEPA-1/PGL-1(wild-type)/-3 droplets (Figures 4I and 4J) . Therefore, mutant PGL-1 proteins promote the transition of PGL droplets into gel-like structures. (K-M) Compared to epg-2 mutant embryos at 20 C (K), far fewer PGL granules and SEPA-1 aggregates are formed in epg-2; pgl-1(bp927) mutants (L) . Left panels show DAPI images of the embryos. Confocal images are shown in (K) and (L) . The number of PGL granules in wild-type and mutant embryos is shown as mean ± SD in (M). *p < 0.05, **p < 0.01. n = 3 focal planes from 3 embryos. Scale bars: 10 mm in (A)- (E), (G)- (I), (K) , and (L), insets in the upper panel of (E) and insets in the two right images of the lower panel of (E); 100 mm in inset for the left image of the lower panel of (E); and 5 mm in insets in (G) and (H) . See also Figure S5 .
The effect of mutant PGL-1 on the formation of SEPA-1/PGL-1/-3 droplets resembles that of EPG-2, which prompted us to investigate the degradation of PGL granules in these pgl-1 mutant embryos. In epg-2 mutants, many PGL granules accumulated ( Figure 4K ) (Tian et al., 2010) . In epg-2; pgl-1(bp924, bp926, and bp927) mutants, the number of PGL granules and SEPA-1 aggregates was dramatically decreased (Figures 4L, 4M, S5U, and S5V) . Thus, mutations in pgl-1 render the degradation of PGL granules independent of EPG-2.
Loss of Function of mTORC1 Signaling Components Suppresses Accumulation of PGL Granules under HeatStress Conditions
In the genetic screen, we also isolated a mutation, sept (suppressor of ectopic PGL granules at high temperature)-6(bp952) that suppressed the accumulation of PGL granules and SEPA-1 aggregates (Figures 5A, 5B, and S6A-S6D) but did not affect the formation of germline P granules ( Figures S6E and S6F) . We found that sept-6 encodes the ortholog of human FNIP2 ( Figures  5C and S6G ).
FNIP2 forms a complex with Folliculin that acts as a GAP for RagC/D to activate mTORC1 in the presence of amino acids ( Saxton and Sabatini, 2017) . Loss of function of the Folliculin homolog, flcn-1, and of other components of mTORC1 signaling, including let-363/tor, mlst-8, daf-15/raptor, rheb-1, raga-1, ragc-1, lmtr-2, and f39c12 .1/mios, also suppressed the accumulation of PGL granules at 26 C ( Figures 5D, 5F , and S6H-S6O). The GATOR1 complex inhibits mTORC1 signaling by acting as a GAP for RagA /B (Saxton and Sabatini, 2017) . Inactivation of GATOR1 complex subunits, including nprl-2 and nprl-3, restored the accumulation of PGL granules in sept-6 mutant embryos at 26 C (Figures 5E and S6P) . Knockdown of rict-1, a component of the mTORC2 complex, did not affect PGL granule accumulation ( Figure S6Q ). Inactivation of mTORC1 also suppressed accumulation of PGL granules in pgl-3(oe) and sepa-1; epg-11 embryos ( Figures S6R-S6U) .
In sept-6 mutants, levels of PGL-1, PGL-3, SEPA-1, and EPG-2 proteins were decreased compared to wild-type embryos at 26 C ( Figure 5G ). The accumulation of PGL granules in sept-6 mutants at 26 C was restored by simultaneous depletion of autophagy genes ( Figures S6V and S6W ). This indicates that inactivation of mTORC1 signaling results in degradation of PGL granules in embryos at 26 C.
Diffuse PGL-1 and PGL-3 Proteins Persist in mTORC1 Inactivation Mutant Embryos Although PGL granules are largely absent in sept-6 mutants at 26 C, levels of PGL-1 and PGL-3 proteins were higher than in wild-type animals grown at 20 C ( Figure 5G ), indicating that PGL-1 and PGL-3 are not effectively removed by autophagy in sept-6 mutants. Consistent with this, GFP::PGL-3 was also diffusely localized in somatic cells in sept-6 and other mTORC1 signaling mutant embryos at 26 C ( Figures 5A, 5B , and S6H-S6O). Simultaneous depletion of sepa-1 increased the level of diffuse GFP::PGL-3 in sept-6 mutants, as in sepa-1 single mutants ( Figures 5H and 5I) . At 26 C, lgg-1; sept-6 mutants contained fewer PGL granules and stronger diffuse GFP::PGL-3 than lgg-1 single mutants ( Figures S6V-S6Y ). sept-6 mutants at 20 C contained higher levels of PGL-1 and PGL-3 proteins and stronger diffuse GFP::PGL-3 than wild-type embryos ( Figures  5G, 5J, and 5K ). SEPA-1 was degraded in sept-6 or let-363(RNAi) mutants ( Figures 5G, S6Z, and S6A2) . Therefore, in mTORC1 signaling mutants, a proportion of PGL-1/-3 proteins fail to condense into granules for degradation and are diffusely localized in the cytoplasm.
LET-363/mTOR Directly Phosphorylates PGL-1 and PGL-3 Using mass spectrometry (MS) to analyze the proteins immunoprecipitated by anti-FLAG::LET-363, we identified PGL-1 and PGL-3 as LET-363-interacting proteins ( Figure S7A) . Incubation of the LET-363 complex with PGL-1 and PGL-3 resulted in a strong thiophosphate-ester signal in in vitro phosphorylation assays ( Figures 6A and S7B ), indicating that PGL-1 and PGL-3 are directly phosphorylated by LET-363.
MS revealed that multiple residues in PGL-1 are phosphorylated by LET-363, including Ser110, Ser340, and Ser650 ( Figures  6B and S7C) . The peptides containing S502/503 and S668/669 were phosphorylated, but the specific phosphorylated residues have yet to be determined ( Figure S7D ). To determine whether mTORC1-mediated phosphorylation of PGL-1 is essential for accumulation of PGL granules at 26 C, the phosphorylated serine residues were mutated to alanine in endogenous PGL-1 by CRISPR/Cas9. The number of PGL granules was decreased in PGL-1(S110A) or PGL-1(S340A) embryos at 26 C and even more dramatically reduced in PGL-1(S110A S340A) embryos ( Figures 6D-6F , S7E, and S7F). Formation of germline P granules was not affected by the S110A S340A mutations (Figures S7G-S7I ). Mutating S502/503, S650, and S668/669 caused no evident decrease in the accumulation of PGL granules ( Figures S7J-S7L ). These results indicate that mTORC1-mediated phosphorylation of PGL-1 is essential for accumulation of PGL granules under heat-stress conditions.
We further developed antibodies against the PGL-1 peptide (aa 103-116) containing phosphorylated Ser110 ( Figures S7M  and S7N) . Immunoblotting with the anti-phosphorylated PGL-1 antibody revealed that levels of phosphorylated PGL-1 were much higher in extracts of embryos grown at 26 C than at 20 C, while phosphorylated PGL-1 was abolished by depletion of sept-6 or raga-1 (Figures 6C and S7O) . Thus, levels of phosphorylated PGL-1 are enhanced under heat-stress conditions. mTORC1 activity, measured by levels of P-4EBP1, remained unchanged at 26 C ( Figure S7P ), indicating that mTORC1 activity is not generally upregulated under this condition. mTORC1-Mediated Phosphorylation Promotes LLPS of SEPA-1/PGL-1/PGL-3 To determine whether mTORC1-mediated phosphorylation of PGL-1/-3 modulates their LLPS, PGL-1, and PGL-3 proteins were phosphorylated by the LET-363 complex and then used for LLPS assays. PGL-1/-3 (0.2 mM for each protein) and SEPA-1/PGL-1/-3 (0.1 mM for each protein) failed to undergo LLPS, but small droplets were formed at the same concentrations when PGL-1 and PGL-3 were phosphorylated ( Figures   6G-6I ). Phosphorylated PGL-1/-3 or SEPA-1/PGL-1/-3 also formed larger droplets compared to non-modified proteins (Figures 6J-6L , S7Q, and S7R). Immunoblotting with the anti-phosphorylated PGL-1 antibody revealed that phosphorylated PGL-1 was present in droplets ( Figure 6M ). The phosphorylated proteins were also more efficiently partitioned into droplets than non-modified PGL-1/-3 ( Figure 6M ). These results indicate that mTORC1-mediated phosphorylation of PGL-1 and PGL-3 lowers the threshold for LLPS and also enlarges the droplets.
PGL Granules Maintain Embryonic Viability under HeatStress Conditions
We investigated the physiological function of PGL granules in embryos at 26 C. C. elegans are usually cultured at a temperature between 15 C and 25 C. Embryos laid by animals grown at 26
C for a long time develop abnormally and fail to hatch. The severity of the abnormality depends on the time the animals are grown at 26 C. Mutants with no PGL granule accumulation under heat stress, including sept-6, sepa-1, pgl-3, pgl-1(bp926 and bp927), pgl-1(S110A S340A), and epg-2(oe), exhibited no developmental abnormality at 20 C, and almost 100% of embryos hatched into larvae ( Figures 7A-7C and 7F) . The embryos laid 20 hr after wild-type animals were shifted to 26 C developed normally ( Figure 7F ). However, survival of embryos laid by mutants was reduced under the same conditions ( Figures 7D-7F ). 83% of embryos laid 40 hr after wild-type animals were shifted to 26 C hatched, but this was greatly reduced to $30% in mutants with no PGL granule accumulation ( Figure 7F ). epg-2 mutant embryos, in which PGL granules accumulate, showed no defect in viability at 20 C or 26 C ( Figure 7F ). Therefore, accumulation of PGL granules maintains embryonic viability during heat stress.
DISCUSSION

SEPA-1 and PTMs Regulate LLPS of PGL-1/-3 to Modulate their Autophagic Degradation
The dynamics and stability of phase-separated compartments as well as the critical concentration of key proteins for phase separation are determined by PTMs and also the composition of the mixture of different proteins that are undergoing LLPS (Banani et al., 2016; Shin et al., 2017) . Here, we showed that LLPS triggers the condensation of PGL-1, PGL-3, and SEPA-1 into droplets. SEPA-1 facilitates LLPS of PGL-1/-3 in a concentration-dependent manner. Arginine methylation attenuates, while mTORC1-mediated phosphorylation enhances, LLPS of PGL-1/-3. This multi-layered regulatory mechanism ensures oocyte-derived PGL-1 and PGL-3 proteins are effectively removed by autophagy in somatic cells ( Figure 7G ). PGL-1 and PGL-3 are present at $1.2 and $0.6 mM in extracts of early-stage embryos (Saha et al., 2016) . As embryogenesis proceeds, their levels decline in somatic cells due to degradation. The expression level of SEPA-1 increases during early embryogenesis, peaking at the 60-100 cell stage (Zhang et al., 2009 ). High SEPA-1 levels promote the condensation of low levels of diffuse PGL-1 and PGL-3 into granules for degradation. Arginine methylation of PGL-1 and PGL-3 causes their separation into granules in a manner that depends on SEPA-1, which associates with EPG-2 (Li et al., 2013). mTORC1-mediated phosphorylation lowers the threshold of PGL-1/-3 for condensation into granules, ensuring that diffuse PGL-1/-3 proteins are effectively removed. These two types of modification act coordinately to control LLPS of PGL-1/-3 and hence the autophagic degradation of PGL granules.
EPG-2 Specifies the Size and Biophysical Properties of PGL-1/-3 Droplets
Phase-separated, liquid-like compartments can mature into more stable structures and can also transition into a less dynamic gel-like state or further into a solid state; these processes . Column scatter charts in (L) show the droplet size in reactions containing non-modified (n = 360 for PGL-1/-3 and n = 314 for SEPA-1/PGL-1/-3) and modified (n = 172 for PGL-1/-3 and n = 126 for SEPA-1/PGL-1/-3) PGL-1/-3. Data are shown as mean ± SEM of droplets combined from three fields (220 3 166 mm) for each reaction.
(M) Phosphorylation of PGL-1 and PGL-3 mediated by the LET-363 complex results in more PGL-1 and PGL-3 proteins partitioning into droplets. Phase separation was induced 2 hr after phosphorylation reactions. Quantification of protein levels (normalized by the levels of the corresponding proteins in the supernatant) is also shown. Scale bars: 10 mm in (E)-(H), (J) , (K) , and insets in (G) , (H) , (J) , and (K) . See also Figure S7 .
are facilitated by an increase in the interaction strength of key molecules (Bergeron-Sandoval et al., 2016; Banani et al., 2017; Shin et al., 2017) . As assessed by resistance to high-salt concentrations and FRAP, PGL droplets mature slowly over time, and this maturation process is enhanced in SEPA-1/PGL-1/-3 droplets. EPG-2 promotes SEPA-1/PGL-1/-3 droplet transition into gel-like structures, which become less dynamic soon after formation, as indicated by their salt resistance and slow FRAP recovery. EPG-2 also controls the size of SEPA-1/PGL-1/-3 droplets, in part by inhibiting droplet fusion. Mutations in PGL-1(P55S, L82P, and E360K) also reduce the size and induce the transition of PGL droplets into gel-like structures. EPG-2 and mutant PGL-1 proteins may increase the local protein concentration in droplets and/or modulate the multivalent interactions to specify the biophysical properties of PGL granules. Therefore, during embryogenesis, EPG-2 controls the size of PGL-1/-3/ SEPA-1 granules, making them amenable to autophagic degradation ( Figure 7G ). The gel-like characteristics of PGL granules may act as a more stable platform than liquid structures for the formation of surrounding autophagosomal membranes. The biophysical properties of protein aggregates modulated by phase separation and transition may affect their degradation in other systems. Stress granules (SGs) are targeted for autophagic degradation (Buchan et al., 2013; Riback et al., 2017) . Amyotrophic lateral sclerosis (ALS) pathogenesis is associated with accumulation of SGs. Mutations in ALS proteins such as FUS and hnRNPA1 or expression of the ALS-associated C09orf72 dipeptide repeats accelerate liquid-to-solid phase transition and SG accumulation (Lin et al., 2015; Molliex et al., 2015; Patel et al., 2015; Lee et al., 2016) . Thus, the solid state of protein aggregates may not be optimal for autophagic degradation.
mTORC1-Mediated PGL Granule Accumulation Confers Heat-Stress Resistance on Embryos
Under heat-stress conditions, PGL-1/-3 fails to be degraded and accumulates into granules in somatic cells. mTORC1 inactivation modulates LLPS-mediated assembly of PGL granules to promote their degradation in embryos under heat stress. When PGL-1/-3 proteins are phosphorylated by LET-363/mTOR, a greater proportion partition into droplets, and the droplets are larger. In embryos grown under heat stress, mTORC1-mediated phosphorylation of PGL-1 and PGL-3 is dramatically enhanced, and thus the size and/or rate of PGL granule formation are increased. EPG-2 is still removed by autophagy, and therefore EPG-2 levels are insufficient to specify the properties of PGL granules that make them amenable to autophagic degradation. In embryos grown under normal conditions, mTORC1-mediated phosphorylation lowers the threshold for LLPS of PGL-1/-3, so that more diffuse PGL-1/-3 proteins condense into granules for degradation. Thus, mTORC1 signaling plays a dual function in modulating the degradation of PGL granules by regulating the phosphorylation levels of PGL-1 and PGL-3. In contrast to the role of mTORC1 in controlling assembly of PGL granules, TORC1 activity is inhibited by its transient sequestration into SGs during heat stress in yeast and osmotic or oxidative stress in mammalian cells (Takahara and Maeda, 2012; Wippich et al., 2013) . Heat-stress-triggered accumulation of PGL granules is an adaptive response during embryogenesis. Mutations that reduce the accumulation of PGL granules, by enhancing their autophagic degradation or impairing their assembly, impair the survival of embryos during heat stress. The stress adaptation function of PGL granules resembles the role of SGs in other organisms. SGs protect mammalian cells from death under various stress conditions and provide a fitness advantage to yeast during prolonged stress (Buchan and Parker, 2009; Riback et al., 2017) . Germline P granules protect the survival and proliferation of nascent germline cells during heat stress. Mutants such as pgl-1 and pptr-1 with defective germline P granules are fertile under normal conditions but become sterile at elevated temperatures (Kawasaki et al., 1998; Gallo et al., 2010) . PGL granules may regulate mRNA translation and stability or sequestrate cell death factors. Our study reveals that mTORC1 signaling modulates phase separation of PGL granules to orchestrate their autophagic degradation and heat-stress adaptation during development.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
C. elegans strains and bacterial strains Strains in this study, including Bristol N2 and mutants derived from the Bristol N2 background, were cultured at 20 C or 26 C on King agar plates seeded with OP50 E. coli. King agar medium: 2.0g NaCl, 20.0g agar, 2.7g peptone, 0.55 g Tris.Base, 0.27 g Tris.HCl and 3.2 mL cholesterol (5 mg/ml) in 1 L. Alleles used in this study listed by chromosome: LGI: sepa-1(bp456), epg-2(bp287), bnIs1 , LGII: lgg-1(bp407), raga-1(ok386), LGIV: sept-6(tm6608), sept-6(bp952), sept-6(bp1337) 
LGV: atg-9(bp564), pgl-3(bp439), him-5(e1490), epg-11(bp292), axIs1464(Ppie-1::gfp::pgl-3, unc-119) , . The location for the following alleles has not been determined: bpIs322(flag::let-363), bpIs336 , . Please see the Key Resources Table for the list of experimental strains used and generated.
METHOD DETAILS
Overexpression of epg-2 or pgl-3::gfp To obtain animals with overexpression of epg-2 or pgl-3::gfp, a fosmid (WRM0614dc06) containing epg-2 genomic DNA was injected at a concentration of 50 ng/ml with sur-5::rfp (20 ng/ml) into wild-type animals or a plasmid containing Psepa-1::pgl-3::gfp was injected at a concentration of 50 ng/ml with an unc-76 expression vector (p76-16B) into unc-76(e911) animals. At least 3 integrated lines were analyzed.
Mapping and cloning of sept-6 bp952 was identified in screens for mutations that suppressed the accumulation of GFP::PGL-1 granules in wild-type embryos at 26 C. Mapping with SNP markers placed bp952 between À9.73 and À8.59 on linkage group IV. All 9 genes located in this region were inactivated by RNAi. t04c4.1(RNAi) suppresses the accumulation of PGL granules at 26 C. t04c4.1(bp1337) , generated by CRISPR/Cas9, and sept-6(tm6608) give rise to the same phenotype and failed to complement sept-6(bp952).
Antibody preparation
To generate an antibody against phosphorylated PGL-1, a peptide containing phosphorylated Ser110 (aa 103-116 of PGL-1) was synthesized and used as an immunogen in rabbits. The antibody was generated by GL Biochem (Shanghai).
Immunoblotting assays
Embryonic extracts were subjected to SDS-PAGE and signals were detected using corresponding primary and secondary antibodies. Anti-actin monoclonal antibody was used as a loading control.
Indirect immunofluorescence assay
Embryos were collected by cutting 30 to 50 gravid hermaphrodites, permeabilized by freeze-cracking, and fixed with methanolacetone (À20 C) then blocked with PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , 1% BSA) for 1 h and incubated with primary antibodies overnight at 4 C. The embryos were then washed 3 times with PBST (PBS+0.2% tween 20) and incubated for 1 h with FITC-or rhodamine-conjugated secondary antibodies. The embryos were then washed 3 times with PBST and observed. Immunofluorescence results are representatives of at least three independent experiments. For quantification of fluorescence intensity of EPG-2 aggregates, the immunofluorescence signal was measured by imageJ and analyzed by Prism (GraphPad).
RNAi inactivation experiments in C. elegans For RNAi inactivation, single-stranded RNA (ssRNA) was transcribed from T7-and SP6-flanked PCR templates. ssRNAs were then annealed and injected into animals carrying various reporters. Injected animals were placed on fresh plates overnight. The embryos laid during the next day were analyzed.
CRISPR/Cas9 experiments
For CRISPR/Cas9 experiments, sgRNA was injected into wild-type animals with a co-injection marker and F1 progeny were examined. sept-6 encodes a protein with 955 amino acids. sept-6(bp1337) mutant animals contain an 11-nucleotide deletion, which introduces a stop codon at codon 398. sept-6(bp1337) failed to complement sept-6(bp952).
Protein expression and purification
All genes were PCR-amplified and cloned into the pET.28a vector to produce His6-tag-fused recombinant proteins, or the pMal.C2X vector to produce MBP-tag-fused recombinant proteins. To express GFP-or Cherry-fused proteins, the GFP or mCherry gene was fused to the 3 0 end of target genes. Point mutations and deletions were introduced by the site-directed mutagenesis approach. All recombinant proteins used in this study were expressed in E. coli BL21-CodonPlus (DE3) induced by 0.3 mM IPTG for 16 h at 18 C and collected by sedimentation. To purify wild-type His-PGL-1/His-PGL-1-GFP and the P55S/L82P/E340K PGL-1 mutants, and His-PGL-3/His-PGL-3-Cherry, the E. coli cells were resuspended in binding buffer (50 mM Tris-Cl pH 7.9, 500 mM NaCl and 10 mM imidazole), lysed with a high-pressure homogenizer and sedimented at 18000 rpm for 30 min to pellet the debris. The supernatant lysates were purified on Ni-NTA agarose beads (QIAGEN). After extensive washing with binding buffer, the proteins were eluted with His6 elution buffer (50 mM Tris-Cl pH 7.9, 500 mM NaCl and 500 mM imidazole), then further purified with a HiPrep 26/60 Sephacryl S-200 HR column (GE Healthcare, 17-1195-01) on an AKTA purifier (GE Healthcare), and eluted with a buffer containing 25 mM HEPES pH 7.5, 1 M NaCl and 1 mM DTT.
To purify His-EPG-2, His-EPG-2-GFP, His-tagged EPG-2 fragments, MBP-SEPA-1, MBP-SEPA-1-CHERRY and MBP-tagged SEPA-1 fragments, the E. coli cells were resuspended in binding buffer (50 mM Tris-Cl pH 7.9, 500 mM NaCl and 10 mM imidazole), lysed with a high-pressure homogenizer and sedimented at 18000 rpm for 30 min to remove the cell debris. The supernatant lysates were purified on Ni-NTA agarose beads (for His6-tagged proteins, QIAGEN) or Amylose Resin (for MBP-tagged proteins, NEB). After extensive washing with binding buffer, the proteins were eluted with His6 elution buffer (50 mM Tris-Cl pH 7.9, 500 mM NaCl and 500 mM imidazole, for His6-tagged proteins) or MBP elution buffer (50 mM Tris-Cl pH 7.9, 500 mM NaCl and 10 mM GSH, for MBP-tagged proteins), then loaded onto a desalting column (GE Healthcare, 17-0851-01) and finally eluted with a buffer containing 25 mM HEPES pH 7.5, 1 M NaCl and 1 mM DTT.
All the purified proteins were concentrated by centrifugal filtrations (Millipore), then stored in aliquots at À80 C.
In vitro phase separation assays Proteins dissolved in buffer containing 25 mM HEPES pH 7.5, 1 M NaCl and 1 mM DTT were mixed at a desired ratio and concentration, and the concentration of NaCl was adjusted to 500 mM with LS buffer (25 mM HEPES pH 7.5 and 1 mM DTT). The concentrated proteins were treated with 0.12 mg/ml RNase A for 1 h at room temperature to examine the effect of RNA on LLPS. The mixtures were centrifuged at 10000 g for 5 min to remove aggregated proteins, and the concentration of NaCl was further adjusted to 150 mM NaCl with LS buffer to induce phase separation. For imaging, droplets were observed either on a glass slide or in a glass-bottom cell culture dish for DIC or fluorescence imaging (Imager M2 from Carl Zeiss and Zeiss LSM 880). For 3D images of the droplets, series of confocal z stacks were taken, and displayed as the maximum intensity projection (Zeiss LSM 880). For 2D images of the droplets, a single confocal plane was shown (Zeiss LSM 880).
For the sedimentation assay, samples were centrifuged at 10000 g for 5 min in a tube. After centrifugation, the supernatant and pellet were immediately separated into two tubes. The pellet fraction was washed once and thoroughly resuspended with buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl and 1 mM DTT so that the volume was the same as the supernatant fraction.
To obtain methylated PGL-1 and PGL-3, His-PGL-1 and His-PGL-3 proteins were incubated with His-EPG-11 in the presence and absence of 0.96 mM S-adenosylmethionine (SAM) in catalytic buffer (25 mM HEPES pH 7.5, 500 mM NaCl and 1 mM DTT) containing protease inhibitor for 2 h at 30 C. The mixtures were then adjusted to 150 mM NaCl to induce phase separation. SEPA-1 was mixed with the methylation system and adjusted to 150 mM NaCl for methyl-PGL-1/-3/SEPA-1 phase separation.
To produce phosphorylated PGL-1 and PGL-3, the LET-363/mTOR complex was purified from worm extracts. Animals expressing flag::let-363 were lysed with lysis buffer (25 mM HEPES pH 7.4, 150 mM NaCl, 1 mM DTT, 0.5% NP-40, 1 mM EDTA, 10% glycerol) containing protease inhibitor. The extracts were then immunoprecipitated with anti-FLAG M2 Affintiy Gel (Sigma, A2220). The immunoprecipitates were washed three times with washing buffer (25 mM HEPES pH 7.4, 300 mM NaCl, 0.5% NP-40, 1 mM EDTA, 10% glycerol) and once with catalytic buffer (25 mM HEPES pH 7.5, 500 mM NaCl and 1 mM DTT). The immunoprecipitated FLAG::LET-363 complex was used for the kinase assay in the presence and absence of 500 mM ATP and recombinant His-PGL-1 or His-PGL-3 proteins purified from E. coli. The reaction mixtures were incubated for 2 h at 30 C in catalytic buffer containing protease inhibitor and 5 mM MgCl 2 . The reaction mixtures were then adjusted to 150 mM NaCl to induce phase separation. SEPA-1 was further added into the mixture to produce p-PGL-1/-3/SEPA-1 droplets.
In vitro phosphorylation assays using ATP-gS In this assay ( Shah and Shokat, 2003) , ATP-gS is used as the phosphate donor to generate the thiophosphorylated substrate, which in turn reacts with p-nitrobenzyl mesylate (PNBM) to form a thiophosphate-ester. The phosphorylated substrate is then detected using a thiophosphate-ester-specific antibody. To detect whether PGL-1 and PGL-3 are directly phosphorylated by LET-363/mTOR, the FLAG::LET-363 complex immunoprecipitated from worm extracts was used for the kinase assay. Recombinant His-PGL-1 or His-PGL-3 proteins purified from E. coli were used as substrates. The reaction mixtures containing 500 mM ATP-gS were incubated for 1 h at 30 C in kinase assay buffer (30 mM HEPES, 50 mM potassium acetate, 5 mM MgCl 2 ) containing protease inhibitor. The reaction mixtures were further supplemented with 2.5 mM p-nitrobenzyl mesylate (PNBM). The alkylating reactions were allowed to proceed for 1 h at 25 C. The reaction systems were analyzed by SDS-PAGE following by western blotting using anti-thiophosphateester antibody.
Fluorescence recovery after photobleaching (FRAP) analysis GFP-tagged PGL-1 proteins were used to label liquid droplets in vitro. To perform the FRAP assay in embryos, PGL-3::GFP proteins were used to label the PGL granules. FRAP experiments were performed on a confocal microscope (LSM 880 Meta plus Zeiss Axiovert zoom, Zeiss) at room temperature. Defined regions were photobleached at 488 nm and the fluorescence intensities in these regions were collected every 2 s (for in vitro droplets) or every 3 s (for PGL granules in embryos) and normalized to the initial intensity before bleaching. Image intensity was measured by Mean ROI and further analyzed by Prism (GraphPad).
3D Fluorescence microscopy and image deconvolution analysis 3D deconvolution images of C. elegans embryos were acquired on the DeltaVision OMX V3 imaging system (GE Healthcare) with a 3 100/1.40 NA oil objective (Olympus UPlanSApo), solid-state multimode lasers (488 nm, 405 nm, 561 nm) and electron-multiplying CCD (charge-coupled device) cameras (Evolve 512 3 512, Photometrics). Serial Z stack sectioning was acquired at 250 nm intervals for conventional mode. To obtain optimal images, immersion oils with refractive indices of 1.512 were used for observing embryos on glass coverslips. The microscope is routinely calibrated with 100 nm fluorescent spheres to calculate both the lateral and axial limits of image resolution. Conventional image stacks were processed by deconvolution methods using softWoRx 5.0 (GE Healthcare) with the following settings: Wiener filter enhancement 0.900; Wiener filter smoothing 0.800. The reconstructed images were further processed for maximum-intensity projections with softWoRx 6.1.1. Pixel registration was corrected to be less than 1 pixel for all channels using 100 nm Tetraspeck beads.
Imaging of embryos and larval/adult animals C. elegans embryos and worms were imaged by microscopy (Imager M2 from Carl Zeiss), processed and viewed using ZEN (blue edition) software (Carl Zeiss). Confocal and spinning disk images of embryos and worms were taken by Zeiss LSM 880 or Nikon Eclipse Ti-E with a spinning-disk confocal scanner unit (UltraView, PerkinElmer).
In-gel digestion of proteins and LC-MS/MS analysis
Gel bands containing the protein sample were manually excised. Each of the protein bands was then digested individually. The protein bands were cut into small plugs and washed twice in 200 mL distilled water for 10 min each time. After reduction (10 mM DTT in 25 mM NH 4 HCO 3 for 45 min at 56 C) and alkylation (40 mM iodoacetamide in 25 mM NH 4 HCO 3 for 45 min at room temperature in the dark) reactions, the gel plugs were digested with trypsin (40 ng for each band) in 25 mM NH 4 HCO 3 overnight at 37 C. The enzymatic reaction was stopped by adding formic acid to a 1% final concentration. The solution was then transferred to a sample vial for LC-MS/MS analysis All nanoLC-MS/MS experiments were performed on a Q Exactive (Thermo Scientific) equipped with an Easy n-LC 1000 HPLC system (Thermo Scientific). The labeled peptides were loaded onto a 100 mm id 3 2 cm fused silica trap column packed in-house with reversed phase silica (Reprosil-Pur C18 AQ, 5 mm, Dr. Maisch GmbH) and then separated on a 75 mm id 3 20 cm C18 column packed with reversed phase silica (Reprosil-Pur C18 AQ, 3 mm, Dr. Maisch GmbH). The peptides bound on the column were eluted with a 75 min linear gradient. Solvent A consisted of 0.1% formic acid in water solution and solvent B consisted of 0.1% formic acid in acetonitrile solution. The segmented gradient was 4%-12% B, 5 min; 12%-22% B, 50 min; 22%-32% B, 12 min; 32%-90% B, 1 min; 90% B, 7 min at a flow rate of 300 nl/min.
The MS analysis was performed with a Q Exactive mass spectrometer (Thermo Scientific). With the data-dependent acquisition mode, the MS data were acquired at a high resolution 70000 (m/z 200) across the mass range of 300-1600 m/z. The target value was 3.00E+06 with a maximum injection time of 60 ms. The top 20 precursor ions were selected from each MS full scan with an isolation width of 2 m/z for fragmentation in the HCD collision cell with normalized collision energy of 27%. Subsequently, MS/MS spectra were acquired at resolution 17500 at m/z 200. The target value was 5.00E+04 with a maximum injection time of 80 ms. The dynamic exclusion time was 40 s. For the nano electrospray ion source setting, the spray voltage was 2.0 kV; no sheath gas flow; the heated capillary temperature was 320 C. For each analysis, 2 mg peptides were injected and each sample was measured in duplicate.
The raw data from Q Exactive were analyzed with Proteome Discovery version 1.4 using Sequest HT search engine for protein identification and Percolator for FDR (false discovery rate) analysis against a Uniprot C. elegans protein database (Proteome ID: UP000001940). Some important searching parameters were set as follows: trypsin was selected as enzyme and two missed cleavages were allowed for searching; the mass tolerance of precursor was set as 10 ppm and the product ions tolerance was 0.02 Da; for phosphorylation site identification, phosphorylation for serine or threonine and methionine oxidation were selected as variable modifications; cysteine carbamidomethylation was selected as a fixed modification. FDR analysis was performed with Percolator and FDR < 1% was set for protein identification. The peptides confidence was set as high for the peptides filter.
Hatching rate of embryos L4 larvae were shifted from 20 C to 26 C for 20 h or 40 h, then transferred to a new plate, where they were allowed to lay embryos for 2 h at 26 C. The animals were then removed. The hatching rate of the embryos was examined at 26 C. The number of embryos was used as the denominator to calculate the percentage of animals that developed to L1 larvae.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the definitions, exact values of n (for studies involving droplets, n refers to the total number of randomly selected fields (220 mm x 166 mm or 105 mm x 105 mm) for each reaction; for studies involving in vitro or in vivo photobleaching experiments, n refers to the number of bleached droplets; for studies involving imaged embryos, n refers to the number of images from the corresponding embryos (3 embryos were used); for studies involving the hatching rate of embryos, n refers to the number of embryos) and statistical significance are reported in the Figures and corresponding Figure Legends . Graphs were generated in GraphPad Prism 5. Statistical analyses were performed in Excel by unpaired Student's t tests; p > 0.05, not significant; *p < 0.05, **p < 0.01 and ***p < 0.001. All data are shown as mean ± SD or mean ± SEM. No statistical methods were used to predetermine the sample size, or to determine whether the data met the assumptions of the statistical approaches used. Figure S1 . LLPS of PGL-1/-3 Is Promoted by SEPA-1, Related to Figure 1 (A-D) DIC images of the droplets formed by 1 mM PGL-3 (A), 1 mM PGL-1 (B) and a mixture of 1 mM each of PGL-1/PGL-3 (C) in a buffer containing 150 mM NaCl. Purified recombinant proteins were used. The reactions were observed 1 min after mixing. PGL-3 forms small droplets. PGL-1 fails to form droplets. The mixture of PGL-1/PGL-3 forms larger droplets under the same conditions. His-tagged PGL-1 and PGL-3 were used for LLPS in this study unless otherwise noted. Column scatter charts in (D) show the size of droplets in reactions containing PGL-3 (n = 173) and PGL-1/-3 (n = 322) at a concentration of 1 mM for each protein. Data are shown as mean ± SEM of droplets combined from three fields (220 mm x 166 mm) for each reaction. (C-F) RNase A treatment of purified PGL-1, PGL-3 and SEPA-1 proteins has no effect on the size and number of droplets formed by PGL-1/-3 (C and D) and SEPA-1/PGL-1/-3 ( E and F) . Purified PGL-1 and PGL-3 proteins were treated with 0.12 mg/ml RNase A for 1 h and then the concentration of NaCl was further adjusted to 150 mM NaCl. (C-F) are DIC images. (G and H) Addition of purified BSA, GFP and MBP (3 mM) has no effect on the LLPS of PGL-1/-3, or on the LLPS-promoting function of SEPA-1. The proteins were pretreated with RNase A. (G and H) 
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